Sangamo Biosciences, Inc. has a market cap of $518.8 million; its shares were traded at around $9.79 with and P/S ratio of 29.5. Sangamo Biosciences, Inc. had an annual average earning growth of 1.6% over the past 5 years.

CFO Recent Trades:

Exec VP & CFO Henry Ward Wolff sold 10,000 shares of SGMO stock on 01/23/2013 at the average price of 10. Henry Ward Wolff owns at least 209,219 shares after this. The price of the stock has decreased by 2.1% since.

Directors and Officers Recent Trades:

Vice President, Research & CSO Philip D Gregory sold 6,000 shares of SGMO stock on 01/02/2013 at the average price of 6.05. Philip D Gregory owns at least 90,000 shares after this. The price of the stock has increased by 61.82% since.

VP, Therapeutic Dev. & CMO Dale G Ando sold 17,000 shares of SGMO stock on 12/26/2012 at the average price of 5.92. Dale G Ando owns at least 88,798 shares after this. The price of the stock has increased by 65.37% since.

Vice President, Research & CSO Philip D Gregory sold 24,000 shares of SGMO stock on 12/10/2012 at the average price of 5.46. Philip D Gregory owns at least 90,000 shares after this. The price of the stock has increased by 79.3% since.

Director John William Larson sold 15,000 shares of SGMO stock on 12/03/2012 at the average price of 5.64. John William Larson owns at least 208,160 shares after this. The price of the stock has increased by 73.58% since.

VP, Therapeutic Dev. & CMO Dale G Ando sold 19,736 shares of SGMO stock on 11/27/2012 at the average price of 5.53. Dale G Ando owns at least 55,798 shares after this. The price of the stock has increased by 77.03% since.

Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.
Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.